Evolution and pharmacological modulation of the arrhythmogenic wave dynamics in canine pulmonary vein model by Colman, Michael et al.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
King’s Research Portal 
 
DOI:
10.1093/europace/eut349
Document Version
Publisher's PDF, also known as Version of record
Link to publication record in King's Research Portal
Citation for published version (APA):
Colman, M., Varela, M., Hancox, J. C., Zhang, H., & Aslanidi, O. (2014). Evolution and pharmacological
modulation of the arrhythmogenic wave dynamics in canine pulmonary vein model. EUROPACE, 16(3), 416-
423. https://doi.org/10.1093/europace/eut349
Citing this paper
Please note that where the full-text provided on King's Research Portal is the Author Accepted Manuscript or Post-Print version this may
differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version for pagination,
volume/issue, and date of publication details. And where the final published version is provided on the Research Portal, if citing you are
again advised to check the publisher's website for any subsequent corrections.
General rights
Copyright and moral rights for the publications made accessible in the Research Portal are retained by the authors and/or other copyright
owners and it is a condition of accessing publications that users recognize and abide by the legal requirements associated with these rights.
•Users may download and print one copy of any publication from the Research Portal for the purpose of private study or research.
•You may not further distribute the material or use it for any profit-making activity or commercial gain
•You may freely distribute the URL identifying the publication in the Research Portal
Take down policy
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing details, and we will remove access to
the work immediately and investigate your claim.
Download date: 10. Jul. 2020
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
FOCUSED ISSUE: ORIGINAL RESEARCH
Evolution and pharmacological modulation
of the arrhythmogenic wave dynamics in canine
pulmonary vein model
Michael A. Colman1, Marta Varela2, Jules C. Hancox3, Henggui Zhang1
and Oleg V. Aslanidi2*
1Biological Physics Group, School of Physics & Astronomy, University of Manchester, Manchester M13 9PL, UK; 2Department of Biomedical Engineering, Division of Imaging Sciences &
Biomedical Engineering, King’s College London, St Thomas’ Hospital, London SE1 7EH, UK; and 3Department of Physiology & Pharmacology, School of Medical Science, University of
Bristol, Bristol BS8 1TD, UK
Received 15 July 2013; accepted after revision 2 October 2013
Aims Atrial fibrillation (AF), the commonest cardiac arrhythmia, hasbeen strongly linked with arrhythmogenic sourcesnear the
pulmonary veins (PVs), but underlying mechanisms are not fully understood. We aim to study the generation and susten-
ance of wave sources in a model of the PV tissue.
Methods
and results
A previously developed biophysically detailed three-dimensional canine atrial model is applied. Effects of AF-induced
electrical remodelling are introduced based on published experimental data, as changes of ion channel currents
(ICaL, IK1, Ito, and IKur), the action potential (AP) and cell-to-cell coupling levels. Pharmacological effects are introduced
by blocking specific ion channel currents. A combination of electrical heterogeneity (AP tissue gradients of 5–12 ms)
and anisotropy (conduction velocities of 0.75–1.25 and 0.21–0.31 m/s along and transverse to atrial fibres) can results
in the generation of wave breaks in the PV region. However, a long wavelength (171 mm) prevents the wave breaks
from developing into re-entry. Electrical remodelling leads to decreases in the AP duration, conduction velocity and wave-
length (to 49 mm), such that re-entry becomes sustained. Pharmacological effects on the tissue heterogeneity and vulner-
ability (to wave breaks and re-entry) are quantified to show that drugs that increase the wavelength and stop re-entry (IK1
and IKur blockers) can also increase the heterogeneity (AP gradients of 26–27 ms) and the likelihood of wave breaks.
Conclusion Biophysical modelling reveals large conduction block areas near the PVs, which are due to discontinuous fibre arrange-
ment enhanced by electrical heterogeneity. Vulnerability to re-entry in such areas can be modulated by pharmacological
interventions.- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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Introduction
Atrial fibrillation (AF) self-perpetuates by multifactor electrical re-
modelling in the atria, which can explain the high prevalence and
treatment-resistant nature of this commonest sustained arrhythmia.
The myocardial sleeves of the pulmonary veins (PVs) extending into
the left atrium (LA) have been recognized as the primary sources of
high-frequency electrical activity during AF, and PV ablation is rou-
tinely used to terminate AF clinically.1 –3 However, mechanisms by
which the PVs can sustain arrhythmogenic activity are unclear, and
its clinical treatments have significant intrinsic limitations.3
Experimental4,5 and computational6,7 studies of the PV sleeves in
animal models reveal substantial electrical heterogeneities and
complex arrangements of myocardial fibres resulting in conduction
discontinuities and unstable re-entrant waves. Similar activation pat-
terns have been observed at the PV-LA junctions during catheter
mapping in AF patients,8,9 leading to suggestions that high-frequency
activity in the PV can be sustained by re-entry.2,3,8 Stable re-entrant
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patternshave recently been simulated using computational models of
the human atria:10 the study has demonstrated effects of electrical re-
modelling on AF self-perpetuation by re-entry, but did not consider
anisotropy of the PVs.
Multiple experimental studies have shown that AF-induced elec-
trical remodelling is characterized by decreases in atrial action poten-
tial duration (APD),9 – 11 which are associated with underlying
changes to the expression of several membrane ion channels
reported both in dog11,12 andhuman.13–15 At the tissue level, remod-
elling has also been linked with down-regulation and heterogeneous
expression of connexin proteins that form intercellular gap junctions
(responsible for the AP conduction), as well as the presence of severe
fibrosis and fibre disorganization.16–18 The latter factors may con-
tribute to decreases in the AP conduction velocity (CV)19 and
increases in conduction anisotropy4 during AF.
A lack of mechanistic understanding of factors underlying AF onset
andevolutionmayexplain relatively lowsuccess rates in its clinical treat-
ment, with 30–50% recurrence even after expensive ablation and
cardioversionprocedures.20,21Availableanti-arrhythmicdrugtherapies
for AF also have moderate effectiveness and risk of life-threatening
proarrhythmic complications.22 Knowledge of the underlying mechan-
isms mayassist in tailoring the drug therapies to the evolving AF dynam-
ics, and hence in increasing the efficacy and safety of pharmacological
treatments for various AF cases. Biophysically detailed models can
help to dissect such electro-pharmacological mechanisms.23–25
In this study,we apply a detailed electrically heterogeneous and an-
isotropic model of the canine PV region6 to (i) incorporate effects on
ion channel and gap junction remodelling seen in chronic AF in
dog;11,12,19 (ii) investigate the evolution of arrhythmic re-entrant sub-
strate for AF due to such effects, and (iii) dissect potential pharmaco-
logical interventions that can terminate the re-entrant activity.
Methods
Single cell models
The Ramirez–Nattel–Courtemanche26 model is used to simulate the
ion channel currents contributing to the AP of a single canine atrial
myocyte. This model is modified to incorporate detailed the current
density data specific to the canine LA and PV cells (Figure 1 and
Table 1), as in a previous study.27 The resultant AP in the PV cell has a
shorter APD and more positive resting potential than the LA cell
(Figure 1B). Atrial fibrillation-induced electrical remodelling is also incor-
porated into the model based on experimental ion channel current mea-
surements from dog12 (Table 1). This involves a reduction of the
conductance of the L-type calcium channel current, ICaL, by 50%, a reduc-
tion of the conductance of the transient outward potassium channel
current, Ito, of 55% and an increase in the conductance of the voltage-
dependant potassium channel current, IK1, of 100%. Such modifications
are consistent with those observed in human, wherein there are more
available data.10,14,15 A previous study has demonstrated the important
role that remodelling of the ultra-rapid potassium channel current, IKur,
may play in the behaviour of AF in electrophysiologically heterogeneous
human atrial tissue.10 Because IKur is atrial-specific, it may be particularly
relevant to drug studies where it can be targeted without any adverse
effects on the ventricles. Therefore remodelling of this ion channel is
also included in the canine cell models. Due to a lack of available canine
data regarding remodelling of this current, a 50% reduction of IKur
(Table 1) is incorporated, which is consistent with data from
human.28,29 Ion channel remodelling shortens the APD of both cell
models (Table 1) and reduces the LA-PV heterogeneity.
Three-dimensional tissue model
To simulate electrical activity in the PV at the tissue scale, a previously
developed three-dimensional (3D) anatomical model of the canine PVs
and inter-pulmonary region of the posterior LA6 is used (Figure 1A).
This model includes fine details of the fibre micro-architecture in this
region, attained from high-resolution micro-CT images (Figure 1C and
D). Details of the reconstruction have been described previously.6,30 Im-
portantly for this study, abrupt changes in the fibre arrangements are
observed at junctions of the PVs and LA, such as the ostium of the left su-
perior pulmonary vein (LSPV) (Figure 1D). Similar abrupt changes have
been observed in experimental electro-anatomical studies.4,31
Action potential conduction is simulated by solving the mono-domain
equation32 on a 3D tissue geometry grid, as described previously.6,33
Conduction anisotropy, defined as the ratio between diffusion coeffi-
cients (characterizing electrotonic cell-to-cell coupling) in the longitudin-
al and transverse fibre directions, is 16 : 1 in the PVs and 10 : 1 in the LA.
These correspond to experimentally validated CV values in the PV and
LA tissue regions.6 Cell-to-cell coupling reduction is introduced by de-
creasing the diffusion coefficients by 50%. This corresponds to the abbre-
viation in AP conduction velocities associated with AF, experimentally
observed to be around 10–40% in various stages of remodelling.17,18 In
the 3D model, this resulted in decreases of the maximum longitudinal
CV from 1.25 to 0.75 m/s and the minimum transverse CV from 0.31
to 0.21 m/s. Note that atrial tissue remodelling can be underlain by mul-
tiple pathophysiological factors, such as down-regulation and heteroge-
neous expression of gap junction proteins, atrial dilatation, and fibrosis.
However, establishing links with the specific factors was beyond the
scope of this study.
Vulnerability to re-entry
Vulnerability to the initiation and sustenance of re-entrant waves under-
lying AF is analysed by measuring the time vulnerability windows to
What’s new?
† Electrophysiologically and anatomically detailed 3D model of
the pulmonary veins developed to study the effects of electric-
al tissue remodelling and anti-arrhythmic drugs;
† Electrical heterogeneity and conduction anisotropy of the
pulmonary veins both contribute to the generation of
pro-arrhythmogenic conduction blocks and wave breaks;
† Cell-to-cell coupling reduction decreases the conduction vel-
ocity and increases the likelihood of wave breaks, but the
linked wavelength decrease is not sufficient for sustained
re-entry;
† Ion channel remodelling (associated with atrial fibrillation)
substantially decreases the action potential duration and
wavelength, and therefore promotes the sustenance of
re-entry;
† Potassium channel current blockers can terminate re-entry by
increasing the action potential duration and wavelength, but
promote wave breaks by increasing electrical heterogeneity;
† Amiodarone can both terminate re-entry and reduce the like-
lihood of wave breaks by substantially decreasing tissue het-
erogeneity and vulnerability to conduction block.
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conduction block leading to (i) at least a singlewavebreak (VWCB) and (ii)
re-entry sustained over several rotations (VWR). An S1-S2 pacing proto-
col is applied toa site combining substantial electrical heterogeneity (such
as the LA-PV junction seen in Figure1A) and structural anisotropy (such as
the LSPV region indicated in Figure 1D), as has been suggested in previous
studies in canine,6 human10,33 and rabbit.34 Three S1 stimuli are applied at
a cycle length of 280 ms, followed by a short-coupled S2 stimulus. The
range of S2 stimuli coupling intervals for which an AP can propagate in
one region (such as the PVs) but is blocked in the other (LA) is considered
as the VWCB. Within this window, the range of S2 stimuli coupling inter-
vals for which this conduction block develops into sustained re-entry
(lasting more than 4 s10) is considered the VWR.
Vulnerability windows are assessed in multiple conditions to dissect
the relative roles of ion channel remodelling, reduced cell-to-cell coup-
ling, electrical heterogeneity and structural anisotropy in the develop-
ment of re-entry. The following conditions are considered: control, full
Figure1 Model of the canine PV region. (A) Three-dimensional segmented geometry, the PVand LA regions are indicated by different colours and
labelled. (B) Segmentation-specific APs in the LA and PV regions. (C ) Fibre orientation in the PV region, atrial fibres are tracked and coloured accord-
ing to the main local fibre orientation component along the anterior-posterior direction.6 (D) Fibre discontinuities near the LSPV ostium. PV, pul-
monary veins, LSPV, left superior pulmonary vein; LIPV, left inferior pulmonary vein; RSPV, right superior pulmonary vein; RIPV, right inferior
pulmonary vein.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1 Electrical heterogeneity and remodelling in the PV-LA regiona
ICa,L (pA/pF) IK1 (pA/pF) Ito (pA/pF) IKs (pA/pF) IKur (pA/pF) APD (ms)
LA control 8.0 (8.5) 5.0 (5.8) 9.0 (8.4) 5.0 (5.3) 10.0 185 (195)
PV control 6.0 (5.9) 3.5 (3.6) 4.5 (5.6) 9.0 (9.8) 10.0 173 (175)
LA remodelled 4.0 (3.4) 10.0 (9.3) 4.0 (3.6) 5.0 (5.0) 5.0 112 (125)
PV remodelled 3.0 (2.6) 7.0 (6.1) 2.0 (2.8) 9.0 (9.8) 5.0 107 (130)
aIon channel current densities and APDs for the PV and LA cell models under control and full remodelling conditions. Simulated values are in good agreement with the respective
experimental values12 shown in brackets. Note that the current density of IKur (step current) in control is the same as in the original paper by Ramirez et al.
26 The current density of IKur
in remodelling conditions is halved as seen in human atrial cells.10
M.A. Colman et al.418
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electrical remodelling (ion channel remodelling and cell-to-cell coupling
reduction), ion channel remodelling only, cell-to-cell coupling reduction
only, full remodelling without heterogeneity and full remodelling without
anisotropy. Heterogeneity is removed by considering all 3D tissue geom-
etry points as PV cells. As a result, differences in both the APD and resting
potential between the LA and PV tissue (Figure1B) areeliminated.Anisot-
ropy is removed by setting the anisotropy ratio to 1 : 1 and adjusting the
diffusion coefficient such that the overall activation time is comparable to
control.6
Pharmacological effects
Models also incorporate the effects of pharmacological ion channel
blockers, to study their potential effectiveness in the prevention and ter-
mination of re-entry. Up-regulation of IK1 associated with AF-induced re-
modelling has been shown to be a primary factor in the APD
abbreviation.35 Hence, this current provides a natural target for reversing
the effects of AF-induced electrical remodelling. Due to the atrial-specific
nature of IKur, this channel also presents an attractive target for a potential
treatment of AF. Along with IK1 and IKur blockade, we also investigate
effects of amiodarone, an exemplary multi-channel blocker that has
proved effective in the treatment of AF.36 Effects of IK1 and IKur blockers
are simulated by reducing their conductances by 50% each. Effects of
amiodarone are simulated by reducing the conductance of ICaL and IKs
by 40 and 50%, respectively.37,38 Drug effects on the APD and its hetero-
geneity between the PV and LA cells are summarized in Table 2.
To study the relative effectiveness of various pharmacological agents on
the prevention of re-entry in different AF cases, we quantify their effects
on the VWCB and VWR in two conditions: (i) full remodelling and
(ii) cell-to-cell coupling reduction only. In these two cases, the pharmaco-
logical effects are introduced from the beginning of the respective simula-
tions. To study the effectiveness of various pharmacological agents in the
termination of re-entry, their effects are introduced in a separate set of
simulations after 4 s of sustained re-entrant activity.
Results
Generation of wave breaks and re-entry
Pacing in the anisotropic and heterogeneous site near the LSPV
resulted in various patterns of wave propagation through the PV
region (Figure 2). These simulations show that all factors considered
(ion channel remodelling, cell-to-cell coupling reduction, heterogen-
eity, anisotropy) are important in the initiation and sustenance of
re-entry. Each of these factors alone can result in conduction block
and wave breaks, although activation patterns (Figure 2) and VWCB
(Table 3) are quantitatively different. However, only the combination
of these factors can result in sustained re-entry (Table 3). In such a
combination, electrical heterogeneity and anisotropy promote a
relatively large VWCB, ion channel remodelling results in a decreased
effective refractory period (ERP, linked to the APD), and coupling re-
duction results in a decreased CV. The short wavelength (WL ¼
ERP × CV) promotes the development of sustained re-entry from
the initial conduction block and wave breaks.
In control (Figure 2A), conduction block of a wave spreading from
the LSPV towards the LA occurs within a large VWCB (18 ms,
Table 3). However, the relatively fast CV and long wavelength
(0.78 m/s and 171 mm, respectively) prevent the wave breaks from
re-entering the LSPV region and generating a complete re-entrant
circuit. With full remodelling (Figure 2B), the same pacing protocol
can generate sustained re-entry. The combination of remodelled
electrical heterogeneity (5 ms, Table 2) and anisotropy results in a
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Drug effects on the APD of the PV and LA cell models in the ion channel remodelling casea
Control Remodelling Remodelling1 IK1 blocker Remodelling1 IKur blocker Remodelling1 amiodarone
LA APD (ms) 185 112 189 138 92
PV APD (ms) 173 107 163 111 89
DAPD (ms) 12 5 26 27 3
aDrug effect on the electrical heterogeneity between the PV and LA cells is also quantified as DAPD.
Figure 2 Generation of conduction blocks in the PV region.
Simulated activation patterns following the LSPV pacing are
shown for different conditions. (A) Control, (B) full remodelling,
(C) cell-to-cell coupling reduction only, (D) ion channel remodelling
only, (E) full remodelling without heterogeneity, (F) full remodelling
without anisotropy.All activation times aremeasured fromthe time
of the applied S2 stimulus. Regions coloured in black indicate areas
in which excitation failed to propagate. The asterisk indicates the lo-
cation of the applied stimuli.
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substantial VWCB (7 ms, Table 3), whereas the decreased velocity
and wavelength (0.47 m/s and 49 mm, respectively) allow for the
wave breaks to complete and sustain a re-entrant circuit. The
mechanisms of transition from the initial conduction block to sus-
tained re-entry (through specific re-entrant conduction pathways)
are discussed in the next section.
With cell-to-cell coupling reduction only, re-entry cannot be
initiated (Figure 2C). The CV is clearly reduced compared to
control (see in Figures 2A and C ), but the wavelength is not further
reduced due to he absence of ion channel remodelling (Table 3).
Therefore, the PVs do not fully recover at the time the wave
returns to the region of initial conduction block, and re-entry fails.
With ion channel remodelling only (Figure 2D), sustained re-entry
cannot be initiated. The short APD (Table 2)—and hence, decreased
ERP and wavelength (Table 3)—allows for a single re-entrant circuit
to be completed, but the relatively fast CV due to the intact
cell-to-cell coupling means the wavelength is still too long to
permit sustained re-entry. Hence, quick self termination of the re-
entrant circuit occurs. Note that VWCB is much wider in the
cell-to-cell coupling reduction case compared to ion channel remod-
elling (Table 3), and hence the reduced coupling is more favourable
for the generation of wave breaks (Figure 2C). However, ion
channel remodelling is more favourable for re-entry (Figure 2B and
D). Each component of full electrical remodelling provides more sub-
strate for re-entry than control.
Both electrical heterogeneity and anisotropy contribute to the
generation of conductionblock and the propagationpatternpromot-
ing sustained re-entry (Figure 2E and F ). Thus, the largest VWCB and
VWR areobserved in the full remodelling condition in thepresence of
both anisotropy and heterogeneity: if either heterogeneity or anisot-
ropy is removed, VWCB is decreased and VWR largely disappears
(Table 3). If heterogeneity is removed, the abrupt fibre angle
change observed at the junction of the PVs and LA by the LSPV
(Figure 1D) is sufficient to result in a conduction block in this region
(Figure 2E). Within a very small window (,1 ms, Table 3) this con-
duction block can develop into sustained re-entry. When anisotropy
is removed, sustained re-entry cannot be initiated (Figure 2F). Note
that VWCB is very similar in the anisotropic and homogeneous
cases (Table 3). Therefore, both the fibre arrangement and electrical
heterogeneity may play an equally important role in the development
of wave breaks.
Transition from wave breaks to re-entry
Transition from wave breaks (arising from a conduction block near
the PVs) to stable, sustained re-entry is illustrated in Figure 3. Primar-
ily, an S2 stimulus applied near the LSPV results in the AP propagating
within the PVs, but blocked from entering the LA (Figure 3Ai). As
described in the previous section, the conduction block occurs at
the LSPV site that combines large electrical heterogeneity and anisot-
ropy. The wave propagates around the block line to the superior part
of the LSPV and the inferior part of the LIPV (Figure 3Ai). These direc-
tions are largely determined by the fibre orientation patterns seen in
Figure 1C and D. The AP propagates along fibre bundles wrapped
around the LSPV and LIPV, eventually entering into the LA from
the posterior and inferior directions (Figure 3Aii). The time needed
for the waves to propagate around the PVs is sufficient for the LA
tissue to recover, hence allowing the waves to propagate into this
region (Figure 3Aiii). The wave then propagates back towards the
site of initial conduction block, where it re-enters the PVs and
travels towards the initiation site (Figure 3Aiii and iv). Afterwards,
the same re-entrant pattern is repeated, with the waves following
the same conduction pathways around the LSPV and LIPV
(Figure 3B). This transitional re-entrant pattern is observed within
the first second of simulation (Figure 3Ci). However, after several
seconds only a single dominant re-entrant wave is sustained around
the LIPV (Figure 3Cii), whereas the second wave is suppressed.
Anti- and pro-arrhythmic drug effects
Application of each ion channel blocker had a significant effect on the
wave behaviour. Sustained re-entry initiated in the full remodelling
condition (Figure 3) was terminated by the application of IK1 (but
not IKur) channel blocker or amiodarone after 4 s of simulating the
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Vulnerability of the PV tissue to re-entry initiation (VWCB) and sustenance (VWR)
a
VWCB (ms) VWR (ms) WL (mm)
Control (no remodelling) 221–239 – 171
Cell-to-cell coupling reduction only 215–243 – 102
Ion channel remodelling only 105–115 – 81
Full remodelling (ion channel + coupling) 103–115 107–109 49
Full remodelling, isotropic tissue 103–110 – 49
Full remodelling, homogeneous tissue 103–111 103 49
Full remodelling + IKur blocker 111–128 – 53
Full remodelling + IK1 blocker 145–167 – 68
Full remodelling + amiodarone 97–101 – 46
Cell-to-cell coupling reduction + IKur blocker 222–246 – 105
Cell-to-cell coupling reduction + IK1 blocker 335–368 – 159
Cell-to-cell coupling reduction + amiodarone 167–183 – 79
aThe vulnerability windows are quantified under various conditions and under effects of various pharmacological agents. The wavelength is measured as WL ¼ ERP × CV, where ERP
corresponds to the lower bound of the VWCB.
M.A. Colman et al.420
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stable re-entrant rotation. Sustained re-entry could not be generated
in the full remodelling condition with the application of either IKur
or IK1 channel blockers or amiodarone (Table 3) at the start of 5 s
simulations.
However, effects of the pharmacological agents on the generation
of wavebreaks were different. Blocking either IKur or IK1 increased the
wavelength, but also increased the extent of the VWCB (Table 3).
Thus, blocking IKur and IK1 increased the VWCB from 12 to 17 and
22 ms, respectively. Therefore, both these channel blockers dis-
played anti-arrhythmogenic effects through increasing the wave-
length and decreasing the likelihood of sustained re-entry, but
pro-arrhythmogenic effects through increasing the electrical hetero-
geneity (Table 2) and likelihood of conduction blocks and wave
breaks (Table 3).Note that conductionblock lines andmultiplewave-
lets have been linked primarily with chronic AF.39,40
Amiodarone was the only drug considered without apparent
pro-arrhythmogenic effects. Apart from preventing the generation
and sustenance of re-entry (seeabove), it also substantially decreased
the VWCB from 12 to 4 ms (Table 3), therefore decreasing the like-
lihood of wave break generation. This is consistent with the clinically
observed superiority of amiodarone over other drugs used for AF
treatment.15,24,36 The underlying electrophysiological mechanism
can be based on the reduction of APD differences between the PV
and LA cells by amiodarone (Table 2). As shown above, such
electrical heterogeneity is important in the generation of both
wave breaks (Table 3) and re-entry (Figure 2E).
Note that the same drugs can result in different wave behaviours in
different AF cases—thus, drug effects in the cell-to-cell coupling re-
duction only case result in very different ERPs and VWs (Table 3).
Discussion
Simulations of a biophysically detailed 3D model of the canine PV
region show that a combination of factors is needed to generate re-
entrant waves: (i) electrical heterogeneity andconduction anisotropy
can lead to pro-arrhythmogenic conduction block lines and wave
breaks; (ii) cell-to-cell coupling reduction decreases the CV and
increases the likelihood of such wave breaks, but does not provide
a substrate for sustained re-entry; (iii) ion channel remodelling
decreases the ERP and promotes the sustenance of re-entry;
(iv) IKur blockers can prevent the generation of transient re-entry,
but cannot prevent the generation of wave breaks or terminate sus-
tained re-entry; (v) IK1 blockers can effectively eliminate re-entrant
substrate by substantially increasing the ERP, but also increase the
likelihood of pro-arrhythmogenic wave breaks by increasing the elec-
trical heterogeneity; and (vi) amiodarone can both eliminate re-
entrant activity and decrease the likelihood of wave breaks.
Figure3 Generation of sustained re-entry in the PV region. Snapshots of re-entrant waves and the resultant activation patterns are shown. (A) and
(B) Initiation and sustenance of re-entry. Timings indicated are following the S2 stimulus. Arrows indicate direction of wavefront propagation.
(C ) Activation patterns during the transient (i) and sustained (ii) rotations of a stable re-entrant wave.
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These results are in agreement with previous experimental and
computational studies. Blockers of repolarising K+ channel currents
are known to reduce effectively the re-entrant substrate size by in-
creasing the APD and wavelength.24 However, currently available
anti-arrhythmic drugs are only moderately effective in preventing
or terminating AF, and may also exert adverse effects.15 Our study
may explain such adverse effects by the increases of the VWCB and
the likelihood of wave breaks in response to blocking IK1 and IKur.
Such wave breaks (rather than re-entry) have been linked with
chronic AF.39,40 This may explain experimental data showing that
the inhibition of IKur can actually promote the induction of AF.
41
Our simulation results may also provide mechanistic insights into
the clinically observed superiority of amiodarone over other drugs
used for AF treatment,15,24,36 as amiodarone uniquely reduces the
likelihood of both re-entry and wave breaks (Table 3).
Results in this study are consistent with those of a previous com-
putational study in humans.10 Inboth studies, ionchannel remodelling
decreased but did not eliminate regional heterogeneity. The pres-
ence of electrical heterogeneity (Table 2) combined with the short
wavelengths (Table 3) associated with both ion channel remodelling
(decreased ERP) and cell-to-cell coupling reduction (decreased CV)
promoted the development of stable high-frequency re-entrant cir-
cuits in both studies. Another previous study allowed for the first
detailed investigation of the role of fibre anisotropy in the develop-
ment and behaviour of re-entrant circuits in the PVs.6 This study
built upon the previous results6,10 by combining detailed electrical
heterogeneity and anisotropy in the PV region6 with electrical re-
modeling,10 as well as the pharmacological effects.37 The results
obtained allow us to dissect factors responsible for various aspects
of wave dynamics underlying AF.
Interestingly, our new results for the first time clearly demonstrate
that abrupt changes in fibre angle alone can produce conduction
blocks, wavebreaks and sustained re-entry (Table 3). Moreover, con-
duction pathways determined by the fibres provide the substrate for
sustaining re-entry (Figure 3). These results are also supported by test
simulations where the LA (rather than the PV) was fast-paced under
the full remodelling condition. As a result of such pacing, an area of
conduction block was observed between the LA and PV regions—
this area had approximately the same location as the conduction
block area seen during the PV pacing under same conditions
(Figure 2), indicating the role of local fibre orientation. The VWCB
due to the LA pacing (108–116 ms) was smaller than that due to
the PV pacing (103–115 ms), as in the latter case the anisotropy
effect was enhanced by the PV-to-LA conduction against the APD
gradient. Thus, the likelihood of wave breaks was lower during the
LA pacing than the PV pacing, and no re-entry was observed during
the LA pacing. More detailed studies are warranted to identify the
most likely areas of re-entry initiation and sustenance in the 3D atria.
Limitations
This study considered the PV region only, as AF is commonly asso-
ciated with this region.1– 7 However, it is important to consider the
behaviour of re-entry within the PVs in the context of the entire
atria. This would enable investigation of the evolution of waves
driven by the PVs at the organ scale, and would also provide a
much larger substrate for wave propagation and re-entry. This may
change the effectiveness of the drugs in terminating re-entry in the
entire atria. For example, IK1 block was successful in terminating
re-entry by increasing the wavelength. Within the small physical sub-
strate of the PVs, the re-entrant wave did not have sufficient space to
perpetuate, and hence self terminated. The effect on re-entry per-
petuation may be different at the larger whole atria scale. A biophy-
sically detailed model for the entire 3D canine atria is currently being
developed.42 Note also that the regional PV model enables more
time efficient study of local tissue properties (such as VWCB).
Similar studies using the entire 3D atria models can be very expensive
computationally.
It is also important to note a simple nature of the models of drug
actions. This study did not consider drug binding kinetics or dose de-
pendencies,43 as well as potential adverseeffects on the other parts on
the heart.22 Such details were not required to achieve the aims of this
study. Our simulation results are in goodagreement with cell-to-tissue
levelelectro-pharmacologicaldata,24,36andmayprovideuseful insights
into the effects of drugs on wave dynamics underlying AF. Moreover,
cell-to-cell coupling reduction in this study was uniform, and the CV
changes were not linked with AF-induced increases in conduction an-
isotropy and levels of fibrosis.16–18 Careful consideration should also
begiventomultiplecellelectrophysiology factors (suchasrelativecon-
tributions of the APD and resting potential to electrical heterogen-
eity), as well as differences between the single cell and intact tissue
experimental data used in the models.12,44,45 Quantifying all these
factors and incorporating them into 3D models could provide a big
challenge for both experimental and computational studies of the
mechanisms of AF sustenance.
Conclusion
The complexity of mechanisms and large variability in pathophysio-
logical factors underlying AF make it likely that distinctive and often
several therapeutic options will be needed for individual AF cases.
In this study, we have applied computational modelling for studying
the evolution and pharmacological modulation of wave dynamics in
the PV tissue under conditions of AF-induced remodelling. Simula-
tion results demonstrated that ion channel remodelling and
cell-to-cell coupling reduction both reduce the wavelength and
promote the development of stable re-entrant circuits, while pre-
serving the substantial electrical heterogeneity and anisotropy to
create the asymmetries necessary for the initiation of wave breaks
and re-entry. Elimination of individual factors (such as atrial hetero-
geneity, anisotropy, ion remodelling, cell-to-cell-coupling reduction)
can lead to the termination of re-entry, but multiple wave breaks still
persist. Pharmacological modulation of the electrical heterogeneity
and vulnerability are also quantified to show that specific drugs that
eliminate re-entry (an anti-arrhythmic effect) can at the same time in-
crease the likelihood of wave breaks (a pro-arrhythmic effect). As 3D
atrial models incorporate increasingly realistic anatomical and func-
tional parameters linked to the development of AF, this should
improve our understanding of electrophysiological mechanisms of
complex wave behaviours underlying various AF cases, as well as
their pharmacological prevention.
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